Unknown

Dataset Information

0

Using B cell receptor lineage structures to predict affinity.


ABSTRACT: We are frequently faced with a large collection of antibodies, and want to select those with highest affinity for their cognate antigen. When developing a first-line therapeutic for a novel pathogen, for instance, we might look for such antibodies in patients that have recovered. There exist effective experimental methods of accomplishing this, such as cell sorting and baiting; however they are time consuming and expensive. Next generation sequencing of B cell receptor (BCR) repertoires offers an additional source of sequences that could be tapped if we had a reliable method of selecting those coding for the best antibodies. In this paper we introduce a method that uses evolutionary information from the family of related sequences that share a naive ancestor to predict the affinity of each resulting antibody for its antigen. When combined with information on the identity of the antigen, this method should provide a source of effective new antibodies. We also introduce a method for a related task: given an antibody of interest and its inferred ancestral lineage, which branches in the tree are likely to harbor key affinity-increasing mutations? We evaluate the performance of these methods on a wide variety of simulated samples, as well as two real data samples. These methods are implemented as part of continuing development of the partis BCR inference package, available at https://github.com/psathyrella/partis. Comments Please post comments or questions on this paper as new issues at https://git.io/Jvxkn.

SUBMITTER: Ralph DK 

PROVIDER: S-EPMC7682889 | biostudies-literature | 2020 Nov

REPOSITORIES: biostudies-literature

altmetric image

Publications

Using B cell receptor lineage structures to predict affinity.

Ralph Duncan K DK   Matsen Frederick A FA  

PLoS computational biology 20201111 11


We are frequently faced with a large collection of antibodies, and want to select those with highest affinity for their cognate antigen. When developing a first-line therapeutic for a novel pathogen, for instance, we might look for such antibodies in patients that have recovered. There exist effective experimental methods of accomplishing this, such as cell sorting and baiting; however they are time consuming and expensive. Next generation sequencing of B cell receptor (BCR) repertoires offers a  ...[more]

Similar Datasets

| S-EPMC5295818 | biostudies-literature
| S-EPMC7055263 | biostudies-literature
| S-EPMC3780890 | biostudies-literature
2017-01-24 | GSE88789 | GEO
| S-EPMC6059956 | biostudies-literature
| S-EPMC4001017 | biostudies-literature
| S-EPMC6735959 | biostudies-literature
| S-EPMC6463697 | biostudies-literature
| S-EPMC4260541 | biostudies-literature
| S-EPMC2211402 | biostudies-literature